PT Indofarma Tbk (ISX:INAF) Change In Payables And Accrued Expense : Rp0 Mil (TTM As of Sep. 2023)

View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk Change In Payables And Accrued Expense?

PT Indofarma Tbk's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2023 was Rp0 Mil. It means PT Indofarma Tbk's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Sep. 2023 .

PT Indofarma Tbk's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was Rp0 Mil. It means PT Indofarma Tbk's Accounts Payable & Accrued Expense stayed the same from Dec. 2021 to Dec. 2022 .

PT Indofarma Tbk Change In Payables And Accrued Expense Historical Data

The historical data trend for PT Indofarma Tbk's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk Change In Payables And Accrued Expense Chart

PT Indofarma Tbk Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

PT Indofarma Tbk Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

PT Indofarma Tbk Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

PT Indofarma Tbk Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Indofarma Tbk (ISX:INAF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530

Website

http://www.indofarma.id

PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines